Abbvie Stock Price. Everything You Need To Know About The Abbvie Stock!
What is Abbvie Stock Price. Everything You Need To Know About The Abbvie Stock!?
AbbVie, Inc. is a biopharmaceutical company that specializes in researching, developing and selling pharmaceutical products. With its headquarters located in North Chicago, Illinois, AbbVie currently employs 50,000 full-time employees. The company went public on 2013-01-02 and has since been offering a range of products in various therapeutic categories. AbbVie's products include immunology products like Humira, Skyrizi, and Rinvoq, oncology products such as Imbruvica and Venclexta, and aesthetics products like Botox Cosmetic, Juvederm Collection, and others. The company also offers neuroscience products such as Botox Therapeutic, Vraylar, Duopa, and Duodopa, Ubrelvy; eye care products like Lumigan, Alphagan, and Restasis; women's health products such as Lo Loestrin, Orilissa, and others. Additionally, AbbVie provides other products like Mavyret, Creon, Lupron, Linzess, and Synthroid. AbbVie's shares are sold to wholesalers, government agencies, healthcare facilities, and independent retailers. As of today, the stock price today for AbbVie, Inc. is available for premarket viewing. With a large market cap, AbbVie, Inc. continues to discover and develop innovative antibody medicines that target difficult-to-drug disease-causing proteins such as G protein-coupled receptors (GPCRs).
Abbvie Stock Price. Everything You Need To Know About The Abbvie Stock! performance
How To Invest In AbbVie Inc Stock From Malaysia, Thailand, Indonesia & Vietnam
Are you looking to invest in the pharmaceutical industry from Malaysia, Thailand, Indonesia, or Vietnam? Abbvie could be the perfect stock for you. As a global biopharmaceutical company, Abbvie is dedicated to discovering, developing, and delivering innovative therapies to help people around the world. With a strong portfolio of products, including market-leading treatments in areas such as immunology, oncology, and neuroscience, Abbvie provides great potential for long-term growth. But how can you invest in this stock? At Zorion, we offer a user-friendly investment platform that allows retail investors from Malaysia, Thailand, Indonesia, and Vietnam to invest in real US stocks like Abbvie. With our investment insights and recommendations, as well as educational resources, you can make informed decisions and further your investment knowledge. Start investing in Abbvie today with Zorion.
How To Buy AbbVie Inc Stock From Malaysia, Thailand, Indonesia & Vietnam
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to buy stocks? Look no further! Zorion, the leading investment platform, offers you the opportunity to invest in various real US stocks and Pre-IPO companies. One such stock on our platform is AbbVie. AbbVie is a renowned pharmaceutical company with a solid track record in developing and producing innovative medical solutions. To buy AbbVie stock from your country, simply sign up on the Zorion platform, where you can access investment insights and recommendations to make informed decisions. Additionally, our platform provides educational materials and resources to enhance your investment knowledge, empowering you to make successful investment choices. Invest in AbbVie through Zorion today and unlock your potential in the stock market!
AbbVie Inc Analytics and Performance
ABBV: A Company in the LIFE SCIENCES Sector and PHARMACEUTICAL PREPARATIONS Industry
Discover AbbVie Inc (ABBV), a prominent player in the LIFE SCIENCES sector, specifically within the PHARMACEUTICAL PREPARATIONS industry. As a Common Stock, ABBV has a strong presence not only in the United States but also in various countries around the world, including its home base USA.
ABBV Financial Performance: Key Ratios and Market Indicators
As of the latest quarter ending 2023-09-30, ABBV boasts an EBITDA of 26254332000 and a trailing price-to-earnings ratio (PE ratio) of 63.11. The forward PE ratio stands at 15.22, which indicates stocks potential in earnings. ABBV's price-to-sales ratio (TTM) is 5.58, and the price-to-book ratio is 25.0. The company's enterprise value-to-revenue and enterprise value-to-EBITDA ratios are 6.44 and 25.85, respectively.
ABBV Stock Stability: Analyzing Marketing Volatility and Trends
ABBV stock performance showcases a beta of 0.542, highlighting moderate volatility. The 52-week high and low prices are 173.96 and 127.03, respectively, with a 50-day moving average of 156.04 and a 200-day moving average of 147.65. With 1765540000 shares outstanding, ABBV demonstrates strong performance in the market.
ABBV Dividends: Current Yields and Shareholder Value
In terms of dividends, AbbVie Inc has a dividend per share of 5.99 and a dividend yield of 0.0362. The company's most recent dividend date was 2024-02-15, and the ex-dividend date was 2024-01-15. ABBV's financials reveal a book value of 6.85 and earnings per share (EPS) of 2.72, with a diluted EPS (TTM) of 2.72.
ABBV Revenue and Profitability: Unveiling the Company's Financial Strength
ABBV revenue per share (TTM) is 30.64, and its total revenue (TTM) amounts to 54317998000. The company's gross profit (TTM) is 41527000000. ABBV's profit margin stands at 0.0895, while the operating margin (TTM) is 0.315. The return on assets (TTM) and return on equity (TTM) are 0.0865 and 0.331, respectively.
ABBV Growth Prospects: Earnings Growth and Analyst Expectations
ABBV has experienced quarterly earnings growth (YOY) of -0.668, but its quarterly revenue growth (YOY) remains stagnant at -0.054. Analysts have set a target price of 174.79 for AbbVie Inc stock.
Want To Buy AbbVie Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: